Insider trades
King-Jones Heidy
King-Jones Heidy made 0 buys and 10 sales on the open market in the last 12 months at Spyre Therapeutics, Inc. Each trade with the role, price and filing.
| Date | Company | Trade | Shares | Price |
|---|---|---|---|---|
| Oct 1, 2026 | Spyre Therapeutics, Inc. | Sale | 400 | US$89.24 |
| Oct 1, 2026 | Spyre Therapeutics, Inc. | Sale | 16,605 | US$90.35 |
| Oct 1, 2026 | Spyre Therapeutics, Inc. | Sale | 7,228 | US$91.35 |
| Oct 1, 2026 | Spyre Therapeutics, Inc. | Sale | 2,100 | US$92.70 |
| Oct 1, 2026 | Spyre Therapeutics, Inc. | Sale | 2,600 | US$93.46 |
| Sep 2, 2026 | Spyre Therapeutics, Inc. | Sale | 400 | US$90.00 |
| Sep 1, 2026 | Spyre Therapeutics, Inc. | Sale | 4,845 | US$86.40 |
| Sep 1, 2026 | Spyre Therapeutics, Inc. | Sale | 16,548 | US$87.20 |
| Sep 1, 2026 | Spyre Therapeutics, Inc. | Sale | 6,206 | US$88.17 |
| Sep 1, 2026 | Spyre Therapeutics, Inc. | Sale | 400 | US$89.38 |